Breaking News

SynaXG Proves the Art of the Possible with Fully Software-Defined AI-RAN on NVIDIA AI Aerial

SynaXG Proves the Art of the Possible with Fully Software-Defined AI-RAN on NVIDIA AI Aerial

SynaXG announced major breakthroughs in AI-native radio access networks, achieving carrier-grade 5G FR1 and FR2 performance on NVIDIA's AI-RAN platform. The system simultaneously operated 20 x 100MHz 5G NR cells delivering over 36Gbps throughput with sub-10ms latency while running AI workloads concurrently. The platform demonstrated 24/7 continuous operation with dynamic GPU resource orchestration, validating readiness for commercial deployment.

Synaxg
3/2/2026, 3:00:00 AM

Latest News

SynaXG Proves the Art of the Possible with Fully Software-Defined AI-RAN on NVIDIA AI Aerial

SynaXG Proves the Art of the Possible with Fully Software-Defined AI-RAN on NVIDIA AI Aerial

SynaXG announced major breakthroughs in AI-native radio access networks, achieving carrier-grade 5G FR1 and FR2 performance on NVIDIA's AI-RAN platform. The system simultaneously operated 20 x 100MHz 5G NR cells delivering over 36Gbps throughput with sub-10ms latency while running AI workloads concurrently. The platform demonstrated 24/7 continuous operation with dynamic GPU resource orchestration, validating readiness for commercial deployment.

Synaxg3/2/2026, 3:00:00 AM
How Will Stocks React to the U.S. Attack on Iran?

How Will Stocks React to the U.S. Attack on Iran?

Following a U.S. and Israeli joint attack on Iran that killed Supreme Leader Ayatollah Ali Khamenei, stock index futures fell while oil and gold futures surged. The article analyzes expected market reactions: defense and energy stocks likely to gain, tech and smaller stocks under pressure, and potential rotation into safer assets like utilities and dividend stocks. Market impact duration depends on investor perception of conflict longevity and severity.

Beth Mckenna3/2/2026, 2:30:31 AM
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires

QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires

QuidelOrtho board director Matthew Strobeck purchased 10,000 shares for ~$240,000 on Feb. 13, 2026, as the company faces another executive transition with CFO Joseph Busky's retirement effective in June. The diagnostics company continues struggling with its third consecutive year of declining revenue and net losses, with stock down ~44% over the past year.

Adé Hennis3/2/2026, 2:18:48 AM
2 Millionaire-Maker Artificial Intelligence (AI) Stocks

2 Millionaire-Maker Artificial Intelligence (AI) Stocks

The article highlights Oracle and Tesla as two AI stocks with significant growth potential. Oracle's cloud computing segment is growing rapidly at 34% year-over-year, driven by major deals like its $300 billion agreement with OpenAI, though the company has taken on substantial debt to fund data center expansion. Tesla is pivoting toward mass production of its Optimus humanoid robot, with plans to launch at $20,000-$30,000 by end of next year, potentially transforming the company beyond electric vehicles.

Patrick Sanders3/2/2026, 1:30:00 AM
Century Aluminum EVP Sells $2.3M Worth of Shares

Century Aluminum EVP Sells $2.3M Worth of Shares

Gunnar Gudlaugsson, EVP of Global Operations at Century Aluminum, sold 43,000 shares worth $2.3 million on February 25, 2026, reducing his direct holdings by 24%. Despite the insider sale, the company remains well-positioned with a landmark partnership with Emirates Global Aluminum to build the first U.S. aluminum smelting plant in 47 years, expected to create 1,000 jobs. Century Aluminum's stock has surged 166% over the past year and is up 31% in 2026.

Adé Hennis3/2/2026, 1:07:06 AM
VTGN DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

VTGN DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

A securities class action lawsuit has been filed against Vistagen Therapeutics regarding alleged material misstatements about its fasedienol drug development for social anxiety disorder. Investors who purchased VTGN stock between April 1, 2024 and December 16, 2025 may be eligible for compensation. The lead plaintiff deadline is March 16, 2026.

Rosen Law Firm3/2/2026, 12:53:00 AM
הודעה על מועד אחרון לתביעה נגד VTGN: רוזן, יועץ מהימן למשקיעים, מעודד את משקיעי Vistagen Therapeutics, Inc להשיג ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך – VTGN

הודעה על מועד אחרון לתביעה נגד VTGN: רוזן, יועץ מהימן למשקיעים, מעודד את משקיעי Vistagen Therapeutics, Inc להשיג ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך – VTGN

Rosen Law Firm announces a March 16, 2026 deadline for investors to join a securities class action lawsuit against Vistagen Therapeutics, Inc. (VTGN). The lawsuit alleges that company defendants made misleading positive statements about the fasedienol drug trial (PALISADE-3) for acute social anxiety disorder treatment while concealing material negative facts, causing shareholders to purchase stock at artificially inflated prices.

Rosen Law Firm3/2/2026, 12:53:00 AM
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Paysafe Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – PSFE

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Paysafe Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – PSFE

Rosen Law Firm is notifying investors who purchased Paysafe Limited securities between March 4, 2025 and November 12, 2025 of an April 7, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Paysafe made false statements regarding its ecommerce business exposure to high-risk clients, understated credit loss reserves, and failed to disclose issues with merchant category codes that would impact revenue growth and ability to meet financial guidance.

Rosen Law Firm3/2/2026, 12:34:00 AM
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PLUG

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PLUG

A securities class action lawsuit has been filed against Plug Power Inc. (PLUG) for allegedly making false and misleading statements regarding a U.S. Department of Energy loan and hydrogen production facilities. Investors who purchased PLUG securities between January 17, 2025 and November 13, 2025 may be eligible for compensation. The lead plaintiff deadline is April 3, 2026.

Rosen Law Firm3/2/2026, 12:10:00 AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR

ROSEN, LEADING INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR

A securities class action lawsuit has been filed against NuScale Power Corporation (NYSE: SMR) for allegedly making false and misleading statements regarding its partnership with ENTRA1 Energy LLC. The lawsuit claims NuScale failed to disclose that ENTRA1 lacked significant experience in nuclear power generation and that the company's commercialization strategy was exposed to material undisclosed risks. Investors who purchased NuScale Class A common stock between May 13, 2025 and November 6, 2025 may be eligible for compensation. The lead plaintiff deadline is April 20, 2026.

Rosen Law Firm3/2/2026, 12:05:00 AM